Nontuberculous mycobacteria infection is increasing in incidence and can lead to chronic, debilitating pulmonary disease. We investigated the accuracy of diagnosis code-based nontuberculous mycobacteria lung disease claims among Medicare beneficiaries in the United States. We observed that these claims have moderate validity, but given their low sensitivity, incidence might be underestimated.
|Original language||English (US)|
|Number of pages||4|
|Journal||Emerging infectious diseases|
|State||Published - Mar 2021|
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases